ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,084.66
      0.72%
      US Tech 100
      17,120.00
      0.84%
      Dow Jones
      38,162.59
      0.20%
      Brent Oil
      88.415
      0.30%
      Bitcoin
      63,979.05
      -0.78%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Pliant Therapeutics Inc (PLRX)

      7. Pliant Therapeutics Inc (PLRX) News

      PLRX Pliant Therapeutics Inc

      11.88
      0.00 (0.00%)
      Pre Market
      Last Updated: 09:24:46
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Pliant Therapeutics Inc PLRX NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.00 0.00% 11.88 09:24:46
      Open Price Low Price High Price Close Price Prev Close
      11.88
      more quote information »

      Recent News

      Date Time Source Heading
      4/25/20248:52IHNWFeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
      4/02/202408:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
      3/27/202410:23GLOBEPliant Therapeutics Announces Upcoming Presentations at the..
      3/12/202407:30GLOBEPliant Therapeutics Announces Accelerated Bexotegrast..
      2/27/202416:20EDGAR2Form S-8 - Securities to be offered to employees in employee..
      2/27/202416:06EDGAR2Form 8-K - Current report
      2/27/202416:03GLOBEPliant Therapeutics Provides Corporate Update and Reports..
      2/26/202408:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
      2/14/202420:55EDGAR2Form SC 13G - Statement of acquisition of beneficial..
      2/14/202408:52EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      2/07/202408:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
      2/05/202407:31EDGAR2Form 8-K - Current report
      2/04/202415:29GLOBEPliant Therapeutics Announces Positive Safety and..
      1/24/202416:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/24/202416:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/24/202416:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/24/202416:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/19/202417:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/19/202417:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/19/202417:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/03/202408:00GLOBEPliant Therapeutics to Participate in the 42nd Annual J.P...
      11/13/202316:30GLOBEPliant Therapeutics Presentations at The Liver Meeting® 2023..
      11/09/202316:11EDGAR2Form 8-K - Current report
      11/09/202316:05GLOBEPliant Therapeutics Provides Corporate Update and Reports..
      11/08/202308:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
      11/06/202308:00GLOBEPliant Therapeutics Presentations at the Annual Meeting of..
      10/31/202316:03GLOBEPliant Therapeutics Announces Three Presentations at the..
      10/19/202308:00GLOBEPliant Therapeutics INTEGRIS-PSC Phase 2a Interim Data..
      10/16/202316:05GLOBEPliant Therapeutics Appoints S. Mishima Gerhart as Chief..
      10/03/202316:53EDGAR2Form 8-K - Current report
      9/26/202307:34EDGAR2Form 8-K - Current report
      9/26/202307:30GLOBEPliant Therapeutics Announces Positive Safety and..
      9/25/202316:05GLOBEPliant Therapeutics to Host Investor Call and Webcast to..
      9/15/202308:00GLOBEPliant Therapeutics Appoints Minnie Kuo as Chief Development..
      9/11/202308:00GLOBEPliant Therapeutics Announces Presentations at the European..
      8/30/202308:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
      8/28/202316:05GLOBEPliant Therapeutics Announces Three Upcoming Presentations..
      8/09/202316:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      8/09/202316:05EDGAR2Form 8-K - Current report
      8/09/202316:03GLOBEPliant Therapeutics Provides Corporate Update and Reports..
      8/09/202308:00GLOBEPliant Therapeutics Announces Initiation of BEACON-IPF, a..
      7/25/202308:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
      7/21/202316:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      7/20/202316:06EDGAR2Form 144 - Report of proposed sale of securities
      7/19/202320:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      7/19/202320:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      7/19/202320:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      7/18/202319:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      7/18/202319:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      7/18/202319:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      6/23/202307:30GLOBEPliant Therapeutics Presents Data from its Bexotegrast..

      Your Recent History

      NASDAQ
      PLRX
      Pliant Therapeutics
      Delayed Upgrade Clock